Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC).

International Journal of Molecular Sciences
Yulan GongSandra V Fernandez

Abstract

To better understand the etiology of inflammatory breast cancer (IBC) and identify potential therapies, we studied genomic alterations in IBC patients. Targeted, next-generation sequencing (NGS) was performed on cell-free DNA (cfDNA) (n = 33) and paired DNA from tumor tissues (n = 29) from 32 IBC patients. We confirmed complementarity between cfDNA and tumor tissue genetic profiles. We found a high incidence of germline variants in IBC patients that could be associated with an increased risk of developing the disease. Furthermore, 31% of IBC patients showed deficiencies in the homologous recombination repair (HRR) pathway (BRCA1, BRCA2, PALB2, RAD51C, ATM, BARD1) making them sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. We also characterized the tumor-infiltrating lymphocytes (TILs) in tumor tissue biopsies by studying several markers (CD4, CD8, FoxP3, CD20, PD-1, and PD-L1) through immunohistochemistry (IHC) staining. In 7 of 24 (29%) patients, tumor biopsies were positive for PD-L1 and PD-1 expression on TILs, making them sensitive to PD-1/PD-L1 blocking therapies. Our results provide a rationale for considering PARP inhibitors and PD-1/PDL1 blocking immunotherapy in qualifying IBC patients.

References

Apr 20, 2004·Cancer Causes & Control : CCC·Phyllis A WingoPaul Gargiullo
Jun 1, 2006·Breast Disease·William F AndersonPaul H Levine
Sep 17, 2009·Journal of the National Cancer Institute·Karen Rowan
Mar 2, 2010·Breast Cancer Research and Treatment·Marijke WasielewskiMieke Schutte
Jun 22, 2010·Cancer·François BertucciPatrice Viens
Jul 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodM Cristofanilli
Jul 20, 2010·Immunological Reviews·Loise M FranciscoArlene H Sharpe
Sep 28, 2010·Nature Structural & Molecular Biology·Rémi BuissonJean-Yves Masson
Oct 21, 2010·CA: a Cancer Journal for Clinicians·Fredika M RobertsonMassimo Cristofanilli
Sep 29, 2011·Cancer·Gad RennertOfra Barnett-Griness
Aug 30, 2013·Science Translational Medicine·Stefani SprangerThomas F Gajewski
Dec 5, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BertucciS J Van Laere
Jul 8, 2014·The Breast : Official Journal of the European Society of Mastology·François BertucciSteven Van Laere
Feb 20, 2015·Molecular Cancer Therapeutics·Sandip Pravin Patel, Razelle Kurzrock
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsUNKNOWN ACMG Laboratory Quality Assurance Committee
Jan 4, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Mary B DalySusan Darlow
Feb 9, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shiping JiaoMien-Chie Hung
Jun 6, 2017·The New England Journal of Medicine·Mark RobsonPierfranco Conte
Jul 26, 2017·Nature Reviews. Clinical Oncology·Wolf H FridmanGuido Kroemer
Apr 29, 2018·Nature Reviews. Cancer·Bora LimNaoto T Ueno
Jul 15, 2018·The Surgical Clinics of North America·Arjun MentaBora Lim
Jul 31, 2018·Nature Reviews. Immunology·Jannie BorstWolfgang Kastenmüller
Aug 16, 2018·The New England Journal of Medicine·Jennifer K LittonJoanne L Blum
Oct 6, 2018·European Journal of Breast Health·Burcu ÇakarRuchan Uslu
Apr 2, 2019·Cancer·Huma Q RanaBeth A Overmoyer
Oct 22, 2019·Gynecologic Oncology·Jennifer Taylor VenerisPanagiotis A Konstantinopoulos
Feb 23, 2020·International Journal of Molecular Sciences·Jennifer S WinnSandra V Fernandez
Dec 4, 2020·Breast Cancer Research : BCR·Sandra V FernandezKerry S Campbell
Jan 21, 2021·The New England Journal of Medicine·UNKNOWN Breast Cancer Association ConsortiumDouglas F Easton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.